The work centres on a question that concerns many cancer patients. What to do when conventional therapies no longer work. This is precisely where the Leipzig centre comes in. Doctors examine the tumour material of patients using modern sequencing methods and analyse genetic changes in the cancer tissue. The aim is to find indications of possible targeted therapies that are individually tailored to each patient. The results are then discussed in a molecular tumour board. In this interdisciplinary committee, experts from various disciplines develop a therapy recommendation based on the genetic characteristics of the tumour. The tumour board works closely with Jena University Hospital as part of the Central German Cancer Centre. With the certification by the German Cancer Society, the Leipzig centre has now received an important confirmation of its quality. At the same time, the step strengthens the role of Central Germany in one of the most dynamic fields of modern medicine in personalised cancer treatment.
News from "Universität Leipzig" on 27 February 2026